Yossi Maimon, VP, Chief Financial Officer at Protalix BioTherapeutics, Inc. (PLX), sold 40,348 shares at $4.00 ($159K) on 2009-05-18, disclosed to the SEC on 2009-05-19.
Open-market sale of $159k PLX by VP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.79 | 10,348 | $39K | 24.6% |
| 2 | $4.00 | 30,000 | $120K | 75.4% |
| Total | $3.95 avg | 40,348 | $159K | 100% |
| Filing → |
| PLX | SELL | 2010-10-08 | $677K | — | Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-10-19 | $1.4M | — | Filing → |